Podcast: Nokia, Audi and Bird & Bird debate FRAND

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Podcast: Nokia, Audi and Bird & Bird debate FRAND

Sponsored by

twobirds-400px.jpg
Clemens Heusch at Nokia (left), Richard Vary at Bird & Bird (middle), Matthias Schneider at Audi (right)

Richard Vary, Clemens Heusch and Matthias Schneider reveal their views on component-level versus end-point licensing and Unwired Planet

To listen to the full podcast, which is around 40 minutes, click the link above.

In the first of three Bird & Bird-sponsored podcasts, Americas editor Patrick Wingrove spoke to Richard Vary, partner at Bird & Bird, Clemens Heusch, global head of dispute resolution at Nokia, and Matthias Schneider, chief licensing officer at Audi, about standard essential patent licensing.

Here, Vary, Heusch and Schneider debate issues of fair, reasonable and non-discriminatory terms in the context of component-level versus end-point licensing, and the recent UK Supreme Court decision in Unwired Planet v Huawei.

We would like to thank Bird & Bird for making this podcast possible and for lending the necessary expertise in this matter. 

To discuss the details of this episode and find out how Bird & Bird can make the most of your IP portfolio, please contact Richard Vary.


more from across site and SHARED ros bottom lb

More from across our site

Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Gift this article